argenx SE (ARGX)
358.50
-7.70
(-2.10%)
USD |
NASDAQ |
Apr 18, 16:00
358.73
+0.23
(+0.06%)
After-Hours: 20:00
argenx Total Liabilities (Quarterly): 444.95M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 444.95M |
| June 30, 2023 | 335.74M |
| December 31, 2022 | 320.56M |
| June 30, 2022 | 279.02M |
| December 31, 2021 | 316.05M |
| June 30, 2021 | 261.09M |
| December 31, 2020 | 605.36M |
| June 30, 2020 | 456.61M |
| December 31, 2019 | 429.81M |
| June 30, 2019 | 390.84M |
| June 30, 2019 | 390.84M |
| December 31, 2018 | 45.83M |
| Date | Value |
|---|---|
| June 30, 2018 | 31.29M |
| June 30, 2018 | 31.29M |
| December 31, 2017 | 31.16M |
| June 30, 2017 | 40.30M |
| December 31, 2016 | 44.59M |
| June 30, 2016 | 46.64M |
| December 31, 2015 | 9.494M |
| June 30, 2015 | 11.60M |
| December 31, 2014 | 10.25M |
| June 30, 2014 | 14.12M |
| March 31, 2014 | 3.668M |
| December 31, 2013 | 4.568M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
261.09M
Minimum
Jun 2021
605.36M
Maximum
Dec 2020
384.62M
Average
390.84M
Median
Jun 2019
Total Liabilities (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 7.957M |
| Trinity Biotech PLC | 81.08M |
| Adaptimmune Therapeutics PLC | 243.10M |
| Merus NV | 99.15M |
| Biophytis SA | 17.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.542B |
| Shareholders Equity (Quarterly) | 4.098B |
| Current Ratio | 9.749 |